Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uterine hemangiopericytoma.

J Buscema, V Klein, J Rotmensch

    Obstetrics and Gynecology
    |January 1, 1987
    PubMed
    Summary

    Malignant behavior was identified in uterine hemangiopericytomas, with recurrences in the pelvis, abdomen, and lungs. Histologic features did not predict this malignant potential.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    Global cross-cultural validation of a brief measure for identifying potential suicide risk in 42 countries.

    Public health·2024
    Same author

    Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial.

    Gynecologic oncology·2020
    Same author

    [Dose constraints to organs at risk for conformational and stereotactic radiotherapy: Small bowel and duodenum].

    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2017
    Same author

    [Standards for treatment in forensic committment according to § 63 and § 64 of the German criminal code : Interdisciplinary task force of the DGPPN].

    Der Nervenarzt·2017

    Area of Science:

    • Gynecologic pathology
    • Oncology
    • Surgical pathology

    Background:

    • Uterine hemangiopericytomas are rare tumors.
    • Understanding their behavior and predicting malignancy is crucial for patient management.

    Purpose of the Study:

    • To analyze the clinicopathologic features of uterine hemangiopericytomas.
    • To identify predictors of malignant behavior and recurrence patterns.

    Main Methods:

    • Clinicopathologic analysis of a series of uterine hemangiopericytomas.
    • Follow-up of 21 patients to assess disease behavior and outcomes.

    Main Results:

    • Malignant behavior was observed in 4 of 21 (19%) patients.
    • Recurrent disease occurred in the pelvis, abdomen, and lungs.
    • No specific histologic features correlated with malignant potential.

    Conclusions:

    • Uterine hemangiopericytomas can exhibit malignant behavior and recur distantly.
    • Current histologic assessment does not reliably predict malignancy.
    • Further research is needed to establish prognostic factors and treatment strategies.

    Related Experiment Videos